United States · FDA National Drug Code directory
Bupropion Hydrochloride SR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-990_4bd451d7-4e0c-3227-e063-6394a90aad6e
- Product NDC
- 71610-990
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- bupropion hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180420
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-990-30) · 71610-990-30
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-990-53) · 71610-990-53
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-990-60) · 71610-990-60
- 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-990-80) · 71610-990-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →